These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16835978)

  • 1. Aspirin and clopidogrel resistance.
    Fosburgh D
    Mayo Clin Proc; 2006 Jul; 81(7):989; author reply 990. PubMed ID: 16835978
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and clopidogrel resistance.
    Michos ED; Ardehali R; Blumenthal RS; Lange RA; Ardehali H
    Mayo Clin Proc; 2006 Apr; 81(4):518-26. PubMed ID: 16610572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin and clopidogrel resistance: an emerging clinical entity.
    Johns A; Fisher M; Knappertz V
    Eur Heart J; 2006 Jul; 27(14):1754; author reply 1754-5. PubMed ID: 16751205
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin, ticlopidine and clopidogrel in and out of the catheterization laboratory.
    Berger PB
    J Invasive Cardiol; 1999 Jun; 11 Suppl A():20A-29A. PubMed ID: 10745607
    [No Abstract]   [Full Text] [Related]  

  • 5. Aspirin or clopidogrel for secondary prevention of cardiovascular events: is there a winner?
    Gaspoz JM; de Moerloose P
    Am J Med; 2004 Jun; 116(12):850-2. PubMed ID: 15178502
    [No Abstract]   [Full Text] [Related]  

  • 6. Clopidogrel and [symbol: see text] ticlopidine--improvements on aspirin?
    Drug Ther Bull; 1999 Aug; 37(8):59-61. PubMed ID: 10696686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "clopidogrel resistance" trap.
    Serebruany VL
    Am J Cardiol; 2007 Sep; 100(6):1044-6. PubMed ID: 17826395
    [No Abstract]   [Full Text] [Related]  

  • 8. Clopidogrel for the prevention of atherothrombotic events.
    Almanaseer Y; Desai DM
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16871689
    [No Abstract]   [Full Text] [Related]  

  • 9. Clopidogrel for the prevention of atherothrombotic events.
    Rozenman Y
    N Engl J Med; 2006 Jul; 355(4):419; author reply 420-1. PubMed ID: 16871688
    [No Abstract]   [Full Text] [Related]  

  • 10. Clopidogrel for the prevention of atherothrombotic events.
    Kongsaengdao S; Arayawichanont A
    N Engl J Med; 2006 Jul; 355(4):419-20; author reply 420-1. PubMed ID: 16874903
    [No Abstract]   [Full Text] [Related]  

  • 11. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease.
    Wong S; Morel-Kopp MC; Chen Q; Appleberg M; Ward CM; Lewis DR
    Thromb Haemost; 2006 Jun; 95(6):1042-3. PubMed ID: 16732389
    [No Abstract]   [Full Text] [Related]  

  • 12. Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
    Wolk MJ; Jacobs AK
    N Engl J Med; 2005 Apr; 352(16):1716-8; author reply 1716-8. PubMed ID: 15843675
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin for cardiovascular disease prevention.
    Janssen JH; Henshaw D
    Med J Aust; 2004 Jan; 180(2):94; author reply 94. PubMed ID: 14723595
    [No Abstract]   [Full Text] [Related]  

  • 14. The charisma of subgroups and the subgroups of CHARISMA.
    Pfeffer MA; Jarcho JA
    N Engl J Med; 2006 Apr; 354(16):1744-6. PubMed ID: 16531617
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggressive antiplatelet strategies: time to reconsider?
    Serebruany VL
    Eur Heart J; 2007 Sep; 28(18):2183-4. PubMed ID: 17673447
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to aspirin and clopidogrel: possible mechanisms, laboratory investigation, and clinical significance.
    Papathanasiou A; Goudevenos J; Tselepis AD
    Hellenic J Cardiol; 2007; 48(6):352-63. PubMed ID: 18196658
    [No Abstract]   [Full Text] [Related]  

  • 18. Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in Canada for patients with established cardiovascular disease: Results from the CHARISMA trial.
    Chen J; Shi C; Mahoney EM; Dunn ES; Rinfret S; Caro JJ; O'Brien J; El-Hadi W; Bhatt DL; Topol EJ; Cohen DJ
    Can J Cardiol; 2011; 27(2):222-31. PubMed ID: 21459271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel for the prevention of atherothrombotic events.
    Kamalesh M
    N Engl J Med; 2006 Jul; 355(4):420; author reply 420-1. PubMed ID: 16874904
    [No Abstract]   [Full Text] [Related]  

  • 20. Lost in translation: what have we learned from the CHARISMA trial?
    DeSilvey DL
    Am J Geriatr Cardiol; 2006; 15(4):260-1. PubMed ID: 16849896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.